Abattis Bioceuticals Corp. (ATTBF)

[guay]

Report of the Task Force on Cannabis Legalization and Regulation
http://www.healthycanadians.gc.ca/task-force-marijuana-groupe-etude/framework-cadre/index-eng.php#a5.6

Implementation
The successful implementation of a regulatory framework for cannabis will take time and require that governments meet a number of challenges with respect to capacity and infrastructure, oversight, co-ordination and communications.

Capacity: Canada's governments will need to move swiftly to increase or create capacity in many areas relating to the production and sale of cannabis. Success requires federal leadership, co-ordination and investment in research and surveillance, laboratory testing, licensing and regulatory inspection, training for law enforcement and others, and the development of tools to increase capacity ahead of regulation. …

To this end, the Task Force recommends that the federal government:
Take a leadership role to ensure that capacity is developed among all levels of government prior to the start of the regulatory regime
Build capacity in key areas, including laboratory testing, licensing and inspection, and training …

… Establishing and promoting laboratory standards: Laboratory testing is a cornerstone of some of the health and safety measures proposed in Chapter 2. Specifically, the mandatory product testing recommended by the Task Force is intended to minimize the risk of contaminated products entering the market and to verify the information on labelling, in order to help consumers make informed decisions. Canada is in the fortunate position of having laboratory standards for cannabis as part of the existing medical cannabis program; as noted in Chapter 3, the capacity of this system will need to be adapted to a new regulatory environment and enhanced so that licensed producers can meet new product safety, quality and labelling requirements. The federal government will play a key role in facilitating this enhancement and ensuring it is capable of meeting the needs of the new regime. …

… Advice to Ministers
The Task Force recommends that the federal government:
Take a leadership role to ensure that capacity is developed among all levels of government prior to the start of the regulatory regime
Build capacity in key areas, including laboratory testing, licensing and inspection, and training
Build upon existing and new organizations to develop and co-ordinate national research and surveillance activities
Provide funding for research, surveillance and monitoring activities …

… Good production practices: In general, ingestible products must meet certain quality standards. In the medical marijuana regime, Health Canada has established product content and production controls that have proven effective in minimizing risks to clients. Similarly, safeguards could be put in place to ensure that marijuana is produced and stored in sanitary and secure conditions. There could be strict security requirements to minimize the possibility of diversion. Controls could be placed on pesticides that can be used, and on microbial and chemical contaminants. Marijuana could also be subject to analytical testing so that those consuming can be reliably advised of its contents, particularly amounts of THC and CBD. …

… The Cannabis Trade Alliance of Canada, which represents producers, said the new regime should provide for mandatory testing:

“Mandatory laboratory testing of all cannabis products (potency and contaminants) – a critical step in the seed-to-sale process when considering public health, and should be the main objective in the legalized framework.” …

Report of the Task Force on Cannabis Legalization and Regulation
http://www.healthycanadians.gc.ca/task-force-marijuana-groupe-etude/framework-cadre/index-eng.php#a5.6